The Scientist

» stem cells

Most Recent

image: STAP Papers Retracted

STAP Papers Retracted

By | July 2, 2014

Nature issues retractions of the stimulus-triggered acquisition of pluripotency papers and pens an editorial on the controversy surrounding their publication.

0 Comments

image: Banking on iPSCs

Banking on iPSCs

By | June 30, 2014

Nature issues retractions of the stimulus-triggered acquisition of pluripotency papers and pens an editorial on the controversy surrounding their publication.

0 Comments

image: Opinion: Thwarting Medical Tourism

Opinion: Thwarting Medical Tourism

By | June 17, 2014

Nature issues retractions of the stimulus-triggered acquisition of pluripotency papers and pens an editorial on the controversy surrounding their publication.

0 Comments

image: Week in Review: June 9–13

Week in Review: June 9–13

By | June 13, 2014

Nature issues retractions of the stimulus-triggered acquisition of pluripotency papers and pens an editorial on the controversy surrounding their publication.

0 Comments

image: Light-Sensing Retina in a Dish

Light-Sensing Retina in a Dish

By | June 10, 2014

Nature issues retractions of the stimulus-triggered acquisition of pluripotency papers and pens an editorial on the controversy surrounding their publication.

0 Comments

image: Week in Review: June 2–6

Week in Review: June 2–6

By | June 6, 2014

Nature issues retractions of the stimulus-triggered acquisition of pluripotency papers and pens an editorial on the controversy surrounding their publication.

0 Comments

image: Minimal Toolkit for Stem Cell Self-Renewal

Minimal Toolkit for Stem Cell Self-Renewal

By | June 5, 2014

Nature issues retractions of the stimulus-triggered acquisition of pluripotency papers and pens an editorial on the controversy surrounding their publication.

0 Comments

image: Final Straw for STAP?

Final Straw for STAP?

By | June 4, 2014

Nature issues retractions of the stimulus-triggered acquisition of pluripotency papers and pens an editorial on the controversy surrounding their publication.

0 Comments

image: Geron hESC Trial to Resume?

Geron hESC Trial to Resume?

By | May 27, 2014

Nature issues retractions of the stimulus-triggered acquisition of pluripotency papers and pens an editorial on the controversy surrounding their publication.

0 Comments

image: Opinion: Pairing Discovery with Regulatory Rigor

Opinion: Pairing Discovery with Regulatory Rigor

By | May 13, 2014

Nature issues retractions of the stimulus-triggered acquisition of pluripotency papers and pens an editorial on the controversy surrounding their publication.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech